NewsBenzingaRBC资本维持对 Doximity 的“跑赢大盘”评级，将目标价上调至 34 美元 RBC资本维持对 Doximity 的“跑赢大盘”评级，将目标价上调至 34 美元 Benzinga 2026.11.06 18:18 (GMT+0) Open on Benzinga Other news Canaccord Genuity Maintains Buy on Redwire, Lowers Price Target to $13 RBC Capital Maintains Outperform on Verastem, Lowers Price Target to $18 Canaccord Genuity Maintains Buy on NuScale Power, Lowers Price Target to $11 RBC Capital Maintains Outperform on Veeva Systems, Raises Price Target to $365 Canaccord Genuity Maintains Buy on TransMedics Group, Raises Price Target to $120 RBC Capital Maintains Outperform on VSE, Raises Price Target to $225
